167 related articles for article (PubMed ID: 25902770)
1. Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process.
Xu Y; Levy BT; Daly JM; Bergus GR; Dunkelberg JC
BMC Health Serv Res; 2015 Apr; 15():175. PubMed ID: 25902770
[TBL] [Abstract][Full Text] [Related]
2. Patients' Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in Korea.
Cho YH; Kim DH; Cha JM; Jeen YT; Moon JS; Kim JO; Lee SK; Cho YK; Im JP; Jang JY; Shin JE; Yoon SM; Jung Y; Kim ES; Lee KN; Cho SJ; Kim Y; Park BY
Gut Liver; 2017 Nov; 11(6):821-827. PubMed ID: 28750489
[TBL] [Abstract][Full Text] [Related]
3. Evaluating preferences for colorectal cancer screening in individuals under age 50 using the Analytic Hierarchy Process.
Hyams T; Golden B; Sammarco J; Sultan S; King-Marshall E; Wang MQ; Curbow B
BMC Health Serv Res; 2021 Jul; 21(1):754. PubMed ID: 34325701
[TBL] [Abstract][Full Text] [Related]
4. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
[TBL] [Abstract][Full Text] [Related]
5. Patient Preferences for Colorectal Cancer Screening Tests in Light of Lowering the Screening Age to 45 Years.
Makaroff KE; Shergill J; Lauzon M; Khalil C; Ahluwalia SC; Spiegel BMR; Almario CV
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):520-531.e10. PubMed ID: 35870766
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study.
Ladabaum U; Mannalithara A; Mitani A; Desai M
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):318-328. PubMed ID: 31796524
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
8. The effects of test preference, test access, and navigation on colorectal cancer screening.
Daskalakis C; Vernon SW; Sifri R; DiCarlo M; Cocroft J; Sendecki JA; Myers RE
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1521-8. PubMed ID: 24813819
[TBL] [Abstract][Full Text] [Related]
9. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
[TBL] [Abstract][Full Text] [Related]
10. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
[TBL] [Abstract][Full Text] [Related]
11. Relationship between risk information on total colonoscopy and patient preferences for colorectal cancer screening options: analysis using the analytic hierarchy process.
Katsumura Y; Yasunaga H; Imamura T; Ohe K; Oyama H
BMC Health Serv Res; 2008 May; 8():106. PubMed ID: 18492286
[TBL] [Abstract][Full Text] [Related]
12. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.
Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR
Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558
[TBL] [Abstract][Full Text] [Related]
15. Preferences and acceptance of colorectal cancer screening in Thailand.
Saengow U; Chongsuwiwatvong V; Geater A; Birch S
Asian Pac J Cancer Prev; 2015; 16(6):2269-76. PubMed ID: 25824749
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting improved compliance towards colonoscopy in individuals with positive faecal immunochemical test (FIT).
Lim TZ; Lau J; Wong GJ; Tan LY; Chang YJ; Natarajan K; Yi H; Wong ML; Tan KK
Cancer Med; 2021 Nov; 10(21):7735-7746. PubMed ID: 34519182
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum U; Mannalithara A
Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
[TBL] [Abstract][Full Text] [Related]
18. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
19. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
20. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
